ELISA, Dot Blot (DB), Immunoassay (IA), Immunohistochemistry (IHC), Western Blotting (WB)
Spezifität
ELISA microtitre plate based and expressed as % crossreactivity*. The antibody exhibited crossreactivity for the following compounds: Norlidocaine < 2.3 %
Aufreinigung
Ig Fraction
Immunogen
Lidocaine-BTG
Applikationshinweise
1.25 µg/mL (EIA)
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
12.10 mg/mL (U.V. abs at 280 nm)
Buffer
20 mM Phosphate, 150 mM NaCl
Lagerung
4 °C
Target
Lidocaine
Substanzklasse
Chemical
Hintergrund
A local anaesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.